Skip to content

7.0T Magnetic Resonance Imaging Study for Hepatic Encephalopathy

7.0T Magnetic Resonance Imaging Study for Hepatic Encephalopathy

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06923254
Enrollment
200
Registered
2025-04-11
Start date
2025-04-03
Completion date
2030-12-24
Last updated
2025-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fMRI Research, Hepatic Encephalopathy (HE), MRI

Keywords

Hepatic Encephalopathy, fMRI

Brief summary

This clinical trial study aims to detect the imaging characteristics of patients with hepatic encephalopathy (HE) using 7-Tesla (7T) magnetic resonance imaging (MRI).

Detailed description

In this study, we analyzed the imaging characteristics of HE. First, with the advantages of 7TMRI, we analyzed the differences in imaging characteristics between HE patients and the healthy, including brain functional imaging and structural imaging. Second, we analyzed the differences in imaging characteristics between different subgroups of HE patients. Finally, we analyzed the correlation between the prognostic results of HE patients after follow-up and the imaging characteristics.

Interventions

OTHER7.0T MRI-Scan

7.0T MRI-Scan

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with clinical suspected or diagnosed hepatic encephalopathy according to relevant guidelines.The patient's education level is above primary school level. * Regular follow-up.

Exclusion criteria

* Contraindications to MRI. * Patients with cerebrovascular disease, brain tumors, epilepsy, other neurodegenerative disease.

Design outcomes

Primary

MeasureTime frameDescription
Functional connectivity and structural alterations between individuals with different subtypes of HE and healthy subjects.5 yearsFunctional connectivity calculation is mainly based on the BOLD sequence, which is used to describe the degree of connectivity between different brain regions and reflect the functional activity of the brain. Gray matter (GM) morphological destruction, cortical thickness, and subcortical nuclear volume in patients with hepatic encephalopathy were analyzed based on structural magnetic resonance imaging(sMRI).

Secondary

MeasureTime frameDescription
Correlation between spectral features of clinical variables and spectral features of imaging.5 yearsThe clinical variable spectrum characteristics were constructed using the patients' medical records and test data. The distribution characteristics of clinical psychological characteristics and imaging spectrum characteristics were compared using a multidimensional matrix, and gene-imaging association analysis was used to evaluate imaging changes.

Countries

China

Contacts

Primary ContactJing Tang
jessietang301@163.com+8618001184224

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026